Two recent court wins by False Claims Act defendants shows the perilous position in which late-filing whistleblowers can find themselves if they want to share in any potential fraud recovery.
Pharmacy services company PharMerica and device maker Biotronik both bested FCA lawsuits filed by whistleblowers bringing allegations that at least in part overlapped with other, earlier filed FCA lawsuits. The whistleblowers, both company insiders, were foiled by the governmental action bar, a provision of the FCA that the U.S. District Court for the District of Rhode Island and U.S. Court of Appeals for the Ninth Circuit said blocked the later-filed lawsuits.
The Department of Justice’s intervention and settlement in the earlier FCA suits barred subsequent whistleblower lawsuits involving similar allegations of fraud, the courts said. The Ninth Circuit said the bar applied even to whistleblower allegations concerning which the DOJ didn’t intervene because the government became a “party” to the entire first whistleblower lawsuit upon intervention.
It’s no surprise that these later filed lawsuits wouldn’t be in the best position to share in any eventual FCA recovery, as the law has a “first-to-file” bar that generally limits subsequent FCA lawsuits containing allegations similar to those in a previously filed FCA action.
The U.S. Supreme Court cracked open the first-to-file bar a bit though when it ruled in 2015 that the bar no longer applies to a second action raising similar allegations if the original FCA lawsuit is dismissed or is no longer pending. PharMerica and Biotronik both faced FCA lawsuits from whistleblowers whose allegations were already the subject of prior lawsuits, and settled with the DOJ for $31.5 million and $4.9 million, respectively.
Megan Mocho Jeschke, a partner with Holland & Knight LLP in McLean, Va., represented Biotronik and told me that the decision by the federal court in Rhode Island in United States ex rel. Estate of Gadbois v. PharMerica Corp. was evidence that the interpretation of the governmental action bar in United States ex rel. Bennett v. Biotronik, Inc. “resonates” with courts across the country. Interestingly, the DOJ filed an amicus brief against Biotronik’s position, arguing that dismissing the second whistleblower lawsuit would generally discourage whistleblowers from coming forward with new fraud allegations.
FCA whistleblower lawsuits can remain under seal for years while the DOJ investigates allegations of fraud against Medicare, Medicaid, or other government programs, so later filing whistleblowers might have no inkling that the DOJ is preparing to intervene in claims similar to their own. The two recent rulings are further evidence of just how important it can be for whistleblowers to win the race to the courthouse.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)